Investor Presentation - First Nine Months of 2016
Investor presentation
First nine months of 2016
Slide 53
The 9% GLP-1 share of the global diabetes care market is
increasing, opportunities for further penetration remain
VictozaⓇ sales and GLP-1 value market share
of total diabetes care market
Global GLP-1 market
GLP-1 value
in bDKK
Share of total
DKK
GLP-1 share of diabetes care market
diabetes care market
billion
50
10%
12
11%
CAGR value¹: 37.0%
40
10
8%
8
00
320
30
6%
VictozaⓇ
6
20
10
4%
4
9%
Exenatide 2%
2
4%
3%
1%
Aug
2011
Other GLP-1
Aug
2016
0%
0
USA
Europe
Pacific
Region
China
IO
1 CAGR for 5-year period
Source: IMS Monthly MAT August, 2016 value figures (DKK)
changing
diabetes®
Source: Novo Nordisk reported sales for first nine months of 2016 and IMS August, 2016 data
novo nordiskView entire presentation